Lifetime Management of Transcatheter Aortic Valve Replacement: A Guide to Decision-Making and Future Reinterventions
Journal of Clinical Medicine · 03.03.2026 · 15 (5) · 1917
DOI: 10.3390/jcm15051917 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 03.03.2026. Verfasst von Malanka Lankaputhra und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of severe aortic stenosis, evolving from a therapy reserved for inoperable patients to a first-line option across all surgical risk categories. As TAVR expands to younger patients with longer life expectancies, lifetime management strategies become paramount. This comprehensive review examines the important role of computed tomography (CT) planning in optimizing initial valve selection and predicting future reintervention feasibility. We discuss the decision framework between TAVR and surgical aortic valve replacement (SAVR) as initial therapy, strategies to optimize the index TAVR procedure, including minimizing patient-prosthesis mismatch, reducing paravalvular regurgitation, preventing conduction abnormalities and coronary obstruction, and facilitating future reinterventions. For patients requiring redo procedures, we analyse TAVR-in-TAVR considerations, including risk plane assessment, coronary access preservation, and leaflet modification techniques. Future directions include advances in valve design, artificial intelligence integration in procedural planning, and development of personalized risk assessment tools. Successful lifetime management requires multidisciplinary collaboration and individualized treatment planning to optimize outcomes throughout a patient’s lifetime journey with aortic valve disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia.
- Department of Cardiology, The Alfred Hospital, Melbourne, VIC 3004, Australia.
- Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
- Department of Cardiology, Victorian Heart Hospital, Clayton, VIC 3168, Australia.
- Department of Cardiology, Peninsula Health, Langwarrin, VIC 3910, Australia.
Zitieren
APA
Lankaputhra, M., Stub, D., Batchelor, R. J., Goel, V., & Htun, N. M. (2026). Lifetime Management of Transcatheter Aortic Valve Replacement: A Guide to Decision-Making and Future Reinterventions. Journal of Clinical Medicine, 15(5), 1917. https://doi.org/10.3390/jcm15051917
Vancouver
Lankaputhra M, Stub D, Batchelor RJ, Goel V, Htun NM. Lifetime Management of Transcatheter Aortic Valve Replacement: A Guide to Decision-Making and Future Reinterventions. Journal of Clinical Medicine. 2026;15(5):1917. doi:10.3390/jcm15051917
BibTeX
@article{Lankaputhra2026,
author = {Lankaputhra, Malanka and Stub, Dion and Batchelor, Riley J and Goel, Vishal and Htun, Nay Min},
title = {Lifetime Management of Transcatheter Aortic Valve Replacement: A Guide to Decision-Making and Future Reinterventions},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {5},
pages = {1917},
doi = {10.3390/jcm15051917}
}
EUVIMED